FINWIRES · TerminalLIVE
FINWIRES

Caliway Biopharma Seeks US FDA Nod for Fat Reduction Drug's Phase 3 Trial; Shares Rise 5%

-- Caliway Biopharmaceuticals (TPE:6919) completed a U.S. FDA IND submission for the phase three clinical trial for a fat reduction drug, according to a Monday Taiwan Exchange filing.

Shares rose about 5% in Tuesday's afternoon trade.

The study will evaluate the drug, dubbed CBL-514, for abdominal subcutaneous fat reduction.

The randomized, double-blind, placebo-controlled trial will enroll about 320 participants across the U.S., Canada and Australia.

The company said the application was submitted on Monday and is currently under review, the filing said.

Related Articles

Australia

Jefferies Raises Quest Diagnostics Price Target to $225 From $220

Quest Diagnostics (DGX) has an average rating of overweight and mean price target of $219, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $204.33, Change: $+8.02, Percent Change: +4.09%

$DGX
Australia

Truist Securities Cuts Tractor Supply Price Target to $44 From $55, Hold Rating Kept

Tractor Supply (TSCO) has an average rating of overweight and mean price target of $56.19, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $39.92, Change: $-4.90, Percent Change: -10.92%

$TSCO
Sectors

Sector Update: Energy

Energy stocks were higher Tuesday afternoon, with the NYSE Energy Sector Index rising 1.1% and the State Street Energy Select Sector SPDR ETF (XLE) adding 1.2%.The Philadelphia Oil Service Sector Index was climbing 1.8%, while the Dow Jones US Utilities Index fell 1.3%.Front-month West Texas Intermediate crude oil was rising 4.8% to $93.94 a barrel, and the global benchmark Brent crude contract was advancing 4.4% to $99.68 a barrel. Henry Hub natural gas futures increased 0.3% to $2.70 per 1 million BTU.In corporate news, Halliburton (HAL) shares gained 4.1% after it reported lower Q1 adjusted net income and revenue that still topped analysts' expectations.

$HAL